Cargando…

A Novel Transthyretin Gene Mutation in Hereditary Transthyretin Amyloidosis: A Case Series of Met13dup Patients

Detalles Bibliográficos
Autores principales:	Jeon, Kina, Kim, Darae, Park, Meesoon, Choi, Jin-Oh, Kim, Kihyun, Kim, Seok Jin, Kim, Jung-Sun, Jeon, Eun Seok
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Cardiology 2023
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172274/ https://www.ncbi.nlm.nih.gov/pubmed/37161749 http://dx.doi.org/10.4070/kcj.2022.0356

Ejemplares similares

Characteristics of South Korean Patients with Hereditary Transthyretin Amyloidosis
por: Choi, Kyomin, et al.
Publicado: (2018)

Untangling Amyloidosis: Recent Advances in Cardiac Amyloidosis
por: Kim, Darae, et al.
Publicado: (2020)

Hereditary transthyretine amyloidosis in Slovenia
por: Zidar, Janez
Publicado: (2015)

Hereditary transthyretin amyloidosis overview
por: Manganelli, Fiore, et al.
Publicado: (2020)

A pilot study of nailfold capillaroscopy in hereditary transthyretin amyloidosis
por: Kim, Dayoung, et al.
Publicado: (2022)

Extracellular Vesicles Contribute to the Metabolism of Transthyretin Amyloid in Hereditary Transthyretin Amyloidosis
por: Yamaguchi, Hiroki, et al.
Publicado: (2022)

Frequency of hereditary transthyretin amyloidosis among elderly patients with transthyretin cardiomyopathy
por: Maestro‐Benedicto, Alba, et al.
Publicado: (2022)

Screening for hereditary transthyretin amyloidosis in Bulgaria
por: Nakov, Radislav, et al.
Publicado: (2021)

Guideline of transthyretin-related hereditary amyloidosis for clinicians
por: Ando, Yukio, et al.
Publicado: (2013)

Hereditary Transthyretin Amyloidosis in Eight Chinese Families
por: Meng, Ling-Chao, et al.
Publicado: (2015)

Burden of hereditary transthyretin amyloidosis on quality of life
por: Yarlas, Aaron, et al.
Publicado: (2019)

Hereditary transthyretin amyloidosis: a case report
por: Lee, Angela, et al.
Publicado: (2022)

Hereditary Transthyretin Amyloidosis with Polyneuropathy: Monitoring and Management
por: Vélez-Santamaría, Valentina, et al.
Publicado: (2022)

Clinical and prognostic implications of capillary density in patients with cardiac light chain amyloidosis
por: Kim, Darae, et al.
Publicado: (2021)

Prognostic values of novel biomarkers in patients with AL amyloidosis
por: Kim, Darae, et al.
Publicado: (2019)

Inotersen: new promise for the treatment of hereditary transthyretin amyloidosis
por: Mathew, Veena, et al.
Publicado: (2019)

Clinical and genetic profiles of hereditary transthyretin amyloidosis in Taiwan
por: Chao, Hua‐Chuan, et al.
Publicado: (2019)

Advances in the treatment of hereditary transthyretin amyloidosis: A review
por: Gertz, Morie A., et al.
Publicado: (2019)

Diagnosis and treatment of heart failure in hereditary transthyretin amyloidosis
por: Puig-Carrion, Gisela D., et al.
Publicado: (2019)

The neuropathy in hereditary transthyretin amyloidosis: A narrative review
por: Tozza, Stefano, et al.
Publicado: (2021)

Accessibility to Occupational Therapy Services for Hereditary Transthyretin Amyloidosis
por: Gayà-Barroso, Aina, et al.
Publicado: (2022)

Conjunctival lymphangiectasia and retinal angiopathy in hereditary transthyretin amyloidosis
por: Patil, Nikhil S., et al.
Publicado: (2022)

Progressive brachial plexus enlargement in hereditary transthyretin amyloidosis
por: Salvalaggio, Alessandro, et al.
Publicado: (2021)

Novel approaches to diagnosis and management of hereditary transthyretin amyloidosis
por: Carroll, Antonia, et al.
Publicado: (2022)

Severe chronic diarrhoea caused by hereditary transthyretin amyloidosis
por: Toppeta, Angelica, et al.
Publicado: (2023)

Prognostic Implication of Longitudinal Changes of Left Ventricular Global Strain After Chemotherapy in Cardiac Light Chain Amyloidosis
por: Bak, Minjung, et al.
Publicado: (2022)

Widespread Cardiac and Vasomotor Autonomic Dysfunction in Non-Val30Met Hereditary Transthyretin Amyloidosis
por: Koike, Haruki, et al.
Publicado: (2018)

Associations of Electrocardiographic Parameters with Left Ventricular Longitudinal Strain and Prognosis in Cardiac Light Chain Amyloidosis
por: Kim, Darae, et al.
Publicado: (2019)

Corrigendum: Prognostic implication of longitudinal changes of left ventricular global strain after chemotherapy in cardiac light chain amyloidosis
por: Bak, Minjung, et al.
Publicado: (2022)

Effects of Tafamidis on Transthyretin Stabilization and Clinical Outcomes in Patients with Non-Val30Met Transthyretin Amyloidosis
por: Merlini, Giampaolo, et al.
Publicado: (2013)

Transthyretin cardiac amyloidosis
por: Tomoaia, Raluca, et al.
Publicado: (2021)

Transthyretin cardiac amyloidosis
por: Porcari, Aldostefano, et al.
Publicado: (2022)

Amyloid fibril composition within hereditary Val30Met (p. Val50Met) transthyretin amyloidosis families
por: Suhr, Ole Bernt, et al.
Publicado: (2019)

Characteristics of Patients with Late- vs. Early-Onset Val30Met Transthyretin Amyloidosis from the Transthyretin Amyloidosis Outcomes Survey (THAOS)
por: Waddington-Cruz, Márcia, et al.
Publicado: (2021)

EGCG-Mediated Protection of Transthyretin Amyloidosis by Stabilizing Transthyretin Tetramers and Disrupting Transthyretin Aggregates
por: Zou, Huizhen, et al.
Publicado: (2023)

Val50Met hereditary transthyretin amyloidosis: not just a medical problem, but a psychosocial burden
por: González-Moreno, Juan, et al.
Publicado: (2021)

Long-term surgical results of trabeculectomy for secondary glaucoma in Val30Met hereditary transthyretin amyloidosis
por: Kitahara, Junya, et al.
Publicado: (2023)

Gastric emptying in hereditary transthyretin amyloidosis: the impact of autonomic neuropathy
por: Wixner, J, et al.
Publicado: (2012)

Mechanism of Action and Clinical Application of Tafamidis in Hereditary Transthyretin Amyloidosis
por: Coelho, Teresa, et al.
Publicado: (2016)

Neuropathy symptom and change: Inotersen treatment of hereditary transthyretin amyloidosis
por: Dyck, P. James B., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fm73vqv90hbb083luq5ngoemhi